share_log

Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?

Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?

以疼痛管理为重点的低价股Virpax药品周三大涨100%,原因是什么?
Benzinga ·  07/10 11:29

Wednesday, Virpax Pharmaceuticals Inc (NASDAQ:VRPX) released results for a Swine Model pilot study for Probudur, Virpax's long-acting liposomal bupivacaine formulation injected at a wound site to provide immediate and extended pain relief.

周三,Virpax Pharmaceuticals Inc (NASDAQ:VRPX) 发布了Probudur的豚鼠模型试验结果。Probudur是Virpax的长效脂质体布比卡因配方,注射到伤口处提供即时和延长的止痛效果。

Shares are trading on a strong session volume of over 100 million, as per data from Benzinga Pro.

根据Benzinga Pro的数据,股票交易的成交量超过10000万,表现强劲。

The pharmacokinetics (PK) and safety study of Probudur in the Swine Model was designed to determine the PK profile of Probudur and to ascertain any adverse effects on the pigs.

Probudur在豚鼠模型的药代动力学(PK)和安全性研究中旨在确定Probudur的PK时间序列和豚鼠的任何不良反应。

Probudur was subcutaneously injected into four juvenile domestic pigs at a dose of 30 mg/kg and was well-tolerated by all of the pigs and demonstrated a long-term, slow-release profile.

Probudur以30 mg / kg剂量皮下注射到四只幼年家养猪身上,所有猪都能很好地耐受,并表现出长期,缓慢释放的特性。

Histopathology was also conducted at the injection site, and Probudur was well-tolerated by all pigs in this study.

注射部位进行了组织病理学检查,Probudur被这个研究中所有豚鼠良好耐受。

"Our study results to date for Probudur, as expected, have consistently been positive and support our belief that Probudur has the potential to provide both immediate relief as well as sustained relief at the wound site," stated Gerald Bruce, CEO of Virpax Pharmaceuticals.

“截至目前,我们对Probudur的研究结果一直是积极的,符合预期,并支持我们的信念:Probudur有可能在伤口处提供即时缓解和持久缓解,” Virpax Pharmaceuticals首席执行官杰拉德·布鲁斯(Gerald Bruce)说道。

"With our agreement to negotiate additional funding from our new institutional investor and remaining necessary studies underway, we continue to target the end of the year for filing our Investigational New Drug Application (IND) for Probudur."

“随着我们与新的机构投资者谈判额外融资,并继续进行必要的研究,我们继续以年底作为提交Probudur的新药申请(IND)的目标,”他称。

Probudur is being developed to reduce or eliminate the need for opioids after surgery in approved indications.

Probudur正在开发用于减少或消除手术后批准适应症中对阿片类药物的需求。

Probudur is a local anesthetic that binds to the sodium channel, preventing pain signals from reaching the brain.

Probudur是一种局部麻醉剂,与钠通道结合,阻止疼痛信号到达大脑。

Probudur has shown long-duration pain control for at least 96 hours in preclinical studies. A rat incisional model demonstrated analgesia for up to five days, and in vitro studies showed a slow release of bupivacaine that lasted for up to six days.

Probudur在临床前研究中表现出长时间的疼痛控制,至少为96小时。大鼠模拟切口模型显示镇痛作用可持续长达五天,在体外研究中,布比卡因缓慢释放持续时间长达六天。

Recently, the company closed a $2.5 million secured loan financing from an institutional investor, which enabled the final payment of its litigation settlement and reorganized and reduced to seven members from eight.

最近,公司从一位机构投资者获得了250万美元的担保贷款融资,这使其能够最终支付诉讼和重组,把股东人数从八人减少到七人。

Price Action: VRPX shares are up 103.5% at $2.36 at last check Wednesday.

市场行情:周三盘中,VRPX的股价涨了103.5%,最新价格为2.36美元。

Photo via Shutterstock

图片来自shutterstock。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发